Related references
Note: Only part of the references are listed.Second Primary Malignancies after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Amrita Y. Krishnan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Second malignancies after autologous hematopoietic cell transplantation in children
K. E. Danner-Koptik et al.
BONE MARROW TRANSPLANTATION (2013)
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
Navneet S. Majhail et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation
Roland Fenk et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Update on the Current State of Melanoma Incidence
Emily G. Little et al.
DERMATOLOGIC CLINICS (2012)
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Michel Attal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Philip L. McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)
Sham Mailankody et al.
BLOOD (2011)
Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma
Corrado Tarella et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Preventive Health Behaviors of Long-Term Survivors of Cancer and Hematopoietic Stem Cell Transplantation Compared with Matched Controls
Michelle M. Bishop et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Hematopoietic Stem Cell Transplantation A Global Perspective
Alois Gratwohl et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation
Paul J. Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Solid cancers after allogeneic hematopoietic cell transplantation
J. Douglas Rizzo et al.
BLOOD (2009)
Cutaneous Melanoma Is Related to Immune Suppression in Kidney Transplant Recipients
Claire M. Vajdic et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma
Tara Seshadri et al.
LEUKEMIA & LYMPHOMA (2009)
Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party
Debra L. Friedman et al.
BLOOD (2008)
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study
Stefano Sacchi et al.
HAEMATOLOGICA (2008)
Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004
Ian Nivison-Smith et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Andrew E. Grulich et al.
LANCET (2007)
Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation:: An EBMT late effects working party study
Amnon Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Lung cancer after treatment for Hodgkin's lymphoma: a systematic review
P Lorigan et al.
LANCET ONCOLOGY (2005)
Second cancers among 40576 testicular cancer patients:: Focus on long-term survivors
LB Travis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis
K Shimada et al.
BONE MARROW TRANSPLANTATION (2005)
Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma
JR Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review
MB Lens et al.
ANNALS OF ONCOLOGY (2005)
Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry
I Nivison-Smith et al.
INTERNAL MEDICINE JOURNAL (2005)
Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: Results of a prospective randomized trial of the German Low Grade Lymphoma Study Group
G Lenz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis
DL Forrest et al.
BONE MARROW TRANSPLANTATION (2003)
New malignancies after blood or marrow stem-cell transplantation in children and adults: Incidence and risk factors
KS Baker et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study
C Metayer et al.
BLOOD (2003)
Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms
C Dong et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
